current glp 1 drugs GLP-1 Costs Explained: Managing Coverage Challenges Indications for GLP-1/GIP RA Summary
Description
Zepbound (tirzepatide) acts as a "dual agonist," targeting both GIP and GLP-1 pathways
Compared to popular GLP-1RAs like semaglutide, orforglipron does not require injection or an absorption enhancer with fasting to achieve exposure, and it can be taken without water or food restrictions, according to Phase 1 pharmacokinetic data
GLP-1 receptor agonists are useful, injectable drugs for the treatment of T2D as they improve glycemic control and atherosclerosis-related parameters [17-26]
[DOI] [PubMed] [Google Scholar] 198.Elahi D., Egan J.M., Shannon R.P., Meneilly G.S., Khatri A., Habener J.F
